A Research Trial on Weekly Insulin vs. Daily Insulin
Phase 3
877
about 1.4 years
18+
103 sites in AL, CA, CO +28
What this study is about
Researchers are testing whether a weekly insulin, called insulin icodec, helps reduce blood sugar compared to daily insulin glargine, both in combination with insulin aspart, in adults with type 1 diabetes. The trial will last for about 8.5 months and involve approximately 877 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Insulin aspart
- 2.Receive Insulin glargine
- 3.Receive Insulin icodec
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
insulin aspart, insulin glargine (Long-acting insulin; helps glucose uptake into cells)
injection
Primary: Change in glycosylated haemoglobin (HbA1c)
Secondary: Change in body weight
Endocrinology